Genetic Technologies Limited (GTG.AX)
AUD 0.04
(0.0%)
AUD 0.04
(0.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 | -6.53 Million AUD | 37.24% |
| 2023 | -10.41 Million AUD | -38.07% |
| 2022 | -7.54 Million AUD | -1.65% |
| 2021 | -7.42 Million AUD | -24.97% |
| 2020 | -5.93 Million AUD | 15.38% |
| 2019 | -7.01 Million AUD | -9.59% |
| 2018 | -6.4 Million AUD | 21.63% |
| 2017 | -8.17 Million AUD | 3.81% |
| 2016 | -8.49 Million AUD | 13.91% |
| 2015 | -9.86 Million AUD | 3.38% |
| 2014 | -10.21 Million AUD | -12.11% |
| 2013 | -9.1 Million AUD | -54.2% |
| 2012 | -5.9 Million AUD | -711.78% |
| 2011 | 965.55 Thousand AUD | 112.57% |
| 2010 | -7.68 Million AUD | 6.75% |
| 2009 | -8.23 Million AUD | -323.4% |
| 2008 | -1.94 Million AUD | -25.09% |
| 2007 | -1.55 Million AUD | 74.78% |
| 2006 | -6.16 Million AUD | 20.58% |
| 2005 | -7.76 Million AUD | -1.45% |
| 2004 | -7.65 Million AUD | -77.0% |
| 2003 | -4.32 Million AUD | 51.28% |
| 2002 | -8.87 Million AUD | -158.76% |
| 2001 | -3.43 Million AUD | -22.31% |
| 2000 | -2.8 Million AUD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 FY | -12.58 Million AUD | -20.78% |
| 2024 Q4 | -3.46 Million AUD | 0.0% |
| 2024 Q2 | -5.16 Million AUD | 0.0% |
| 2023 FY | -10.41 Million AUD | -38.07% |
| 2023 Q2 | -5.39 Million AUD | 0.0% |
| 2023 Q4 | -4.58 Million AUD | 0.0% |
| 2022 FY | -7.54 Million AUD | -1.65% |
| 2022 Q4 | -4.31 Million AUD | -136.28% |
| 2022 Q1 | -1.94 Million AUD | 53.47% |
| 2022 Q2 | -4.97 Million AUD | -155.51% |
| 2022 Q3 | -1.82 Million AUD | 63.28% |
| 2021 Q3 | -1.86 Million AUD | 58.0% |
| 2021 Q2 | -4.44 Million AUD | 0.0% |
| 2021 Q4 | -4.18 Million AUD | -124.05% |
| 2021 FY | -7.42 Million AUD | -24.97% |
| 2020 FY | -5.93 Million AUD | 15.38% |
| 2020 Q2 | -3.08 Million AUD | 0.0% |
| 2020 Q4 | -4.06 Million AUD | 0.0% |
| 2019 FY | -7.01 Million AUD | -9.59% |
| 2019 Q4 | -3.39 Million AUD | 0.0% |
| 2019 Q2 | -3.11 Million AUD | 0.0% |
| 2018 Q4 | -3.02 Million AUD | 0.0% |
| 2018 FY | -6.4 Million AUD | 21.63% |
| 2018 Q2 | -3.37 Million AUD | 0.0% |
| 2017 Q2 | -4.08 Million AUD | 0.0% |
| 2017 Q4 | -3.91 Million AUD | 0.0% |
| 2017 FY | -8.17 Million AUD | 3.81% |
| 2016 FY | -8.49 Million AUD | 13.91% |
| 2016 Q4 | -4.43 Million AUD | 0.0% |
| 2016 Q2 | -4.05 Million AUD | 0.0% |
| 2015 Q4 | -4.19 Million AUD | 0.0% |
| 2015 FY | -9.86 Million AUD | 3.38% |
| 2015 Q2 | -5.66 Million AUD | 0.0% |
| 2014 Q4 | -4.89 Million AUD | 0.0% |
| 2014 FY | -10.21 Million AUD | -12.11% |
| 2014 Q2 | -5.31 Million AUD | 0.0% |
| 2013 Q3 | - AUD | 100.0% |
| 2013 Q4 | -5.51 Million AUD | 0.0% |
| 2013 FY | -9.1 Million AUD | -54.2% |
| 2013 Q2 | -3.8 Million AUD | 0.0% |
| 2012 Q3 | - AUD | 0.0% |
| 2012 Q4 | - AUD | 0.0% |
| 2012 FY | -5.9 Million AUD | -711.78% |
| 2012 Q2 | - AUD | 0.0% |
| 2011 Q4 | - AUD | 0.0% |
| 2011 Q2 | - AUD | 0.0% |
| 2011 FY | 965.55 Thousand AUD | 112.57% |
| 2010 Q4 | - AUD | 0.0% |
| 2010 FY | -7.68 Million AUD | 6.75% |
| 2009 FY | -8.23 Million AUD | -323.4% |
| 2009 Q4 | - AUD | 0.0% |
| 2008 Q4 | -14.35 Million AUD | -316.43% |
| 2008 FY | -1.94 Million AUD | -25.09% |
| 2008 Q1 | 4.42 Million AUD | 149.16% |
| 2008 Q2 | -66.52 Thousand AUD | -101.51% |
| 2008 Q3 | 6.63 Million AUD | 10067.03% |
| 2007 Q4 | -8.99 Million AUD | -312.04% |
| 2007 FY | -1.55 Million AUD | 74.78% |
| 2007 Q3 | 4.24 Million AUD | 267.61% |
| 2007 Q2 | -2.52 Million AUD | -193.41% |
| 2007 Q1 | 2.7 Million AUD | 119.52% |
| 2006 Q4 | -13.87 Million AUD | -640.11% |
| 2006 FY | -6.16 Million AUD | 20.58% |
| 2006 Q1 | 3.37 Million AUD | 118.48% |
| 2006 Q2 | -1.43 Million AUD | -142.63% |
| 2006 Q3 | 2.56 Million AUD | 278.52% |
| 2005 Q3 | 3.55 Million AUD | 2001.27% |
| 2005 Q1 | 3.76 Million AUD | 0.0% |
| 2005 Q4 | -18.26 Million AUD | -614.47% |
| 2005 FY | -7.76 Million AUD | -1.45% |
| 2005 Q2 | -186.77 Thousand AUD | -104.96% |
| 2004 FY | -7.65 Million AUD | -77.0% |
| 2003 FY | -4.32 Million AUD | 51.28% |
| 2002 FY | -8.87 Million AUD | -158.76% |
| 2001 FY | -3.43 Million AUD | -22.31% |
| 2000 FY | -2.8 Million AUD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Australian Clinical Labs Limited | 56.9 Million AUD | 111.488% |
| BCAL Diagnostics Limited | -5.44 Million AUD | -20.01% |
| Genetic Signatures Limited | -22.33 Million AUD | 70.729% |
| Healius Limited | 39.7 Million AUD | 116.466% |
| Imagion Biosystems Limited | -15.81 Million AUD | 58.663% |
| Integral Diagnostics Limited | 5.36 Million AUD | 221.803% |
| INOVIQ Ltd | -9.51 Million AUD | 31.264% |
| Microba Life Sciences Limited | -26.84 Million AUD | 75.647% |
| Monash IVF Group Limited | -5.34 Million AUD | -22.327% |
| Rhythm Biosciences Limited | -6.7 Million AUD | 2.536% |
| Sonic Healthcare Limited | 816.45 Million AUD | 100.801% |